Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
NovoPulse
AddedFeb 18, 2024
UpdatedJun 18, 2026
NovoPulse

NovoPulse

Seed

BioMagnetic Sciences offers non-invasive, joint-specific pain management through their FDA listed device, NovoPulse MKX-1.

HQ
Eden Prairie, MN, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

NovoPulse, founded with the mission to revolutionize pain management, focuses on non-opioid solutions for conditions like osteoarthritis. The company's flagship product, the NovoPulse MKX-1, is an FDA-listed Class I physical therapy device designed to manage spine and joint pain. By integrating pulsed electromagnetic field (PEMF) research with advanced thermal stimulation techniques, NovoPulse aims to improve patients' quality of life by reducing pain and enhancing mobility.

Notable figures associated with NovoPulse include experts in medical device innovation and pain management. The company has garnered attention for its significant achievements, including FDA listing and positive clinical outcomes. NovoPulse's impact is marked by its commitment to providing effective, non-invasive pain relief alternatives, contributing to the broader movement away from opioid dependency in pain treatment.

NovoPulse - Similar Companies

Endonovo Therapeutics logo

Endonovo Therapeutics

endonovo.com

NovoPedics logo

NovoPedics

Carewave Medical logo

Carewave Medical

Soovu Labs logo

Soovu Labs

soovu.com

Hypersound Medical logo

Hypersound Medical

NeuraLace Medical logo

NeuraLace Medical

Ensr Medical logo

Ensr Medical

Novum Medical logo

Novum Medical

OsteoNovus logo

OsteoNovus

osteonovus.com

Prohuman Technologies logo

Prohuman Technologies

Thermaquil logo

Thermaquil

thermaquil.com

Nalu Medical logo

Nalu Medical

nalumed.com

NuPulseCV logo

NuPulseCV

nupulsecv.com

Cerephex logo

Cerephex

cerephex.com

SPR Therapeutics logo

SPR Therapeutics

NovoPulse - Quick Facts

Who are NovoPulse's competitors?

Companies similar to NovoPulse include Endonovo Therapeutics, NovoPedics, Carewave Medical and Soovu Labs.

When was NovoPulse founded?

NovoPulse was founded in 2011.

Where is NovoPulse's headquarters located?

NovoPulse's headquarters is located in Eden Prairie, MN, US.

When was NovoPulse's last funding round?

NovoPulse's most recent funding round was for $274k (USD) in March 2014.

How much has NovoPulse raised to-date?

As of Mar 18, 2014, NovoPulse has raised a total of $274k (USD).

How many employees does NovoPulse have?

NovoPulse has 2 employees as of Feb 4, 2024.

NovoPulse - Classification

Industry
  • Hardware
Technology
  • PEMF
  • Thermal Stimulation
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Osteoarthritis
  • Pain Management
Tags
  • Healthtech
  • Medical Device
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 3 more industry codes
NAICS
  • 621000Ambulatory Health Care Services
  • 621300Offices of Other Health Practitioners
  • 621340Offices of Physical, Occupational and Speech Therapists, and Audiologists